netFormulary Joint Medicines Formulary NHS
Airedale NHS Foundation Trust
Airedale, Wharfedale and Craven CCG
 
 Search
 Formulary Chapter 11: Eye - Full Chapter
Notes:
Unless explicitly stated, any brand names included in brackets next to a drug's generic name are there solely to aid searching and identification, and should not be considered to limit use to that specific brand. 
 Details...
11.08.02  Expand sub section  Ocular diagnostic and peri-operative preparations and photodynamic treatment
11.08.02  Expand sub section  Ocular diagnostic preparations
Fluorescein Sodium (Minims)
(Single Use Eye Drops)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
  • Fluorescein Sodium 2% Minims (preservative free)
     
 
   
11.08.02  Expand sub section  Ocular peri-operative drugs
 note 

Drugs used to prepare the eye for surgery and drugs that are injected into the anterior chamber at the time of surgery are included here.

Acetylcholine and Mannitol
(Intraocular Irrigation)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
  • Acetylcholine 1%, mannitol 3% Intraocular Irrigation when reconstituted (preservative free)

    For Consultant Opthalmologist use only
 
   
Apraclonidine  (Iopidine)
(Eye Drops)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
  • Apraclonidine 1% Eye Drops (24 X 0.25ml) (preservative free)

    For use following consultant recommendation only
 
   
Diclofenac Sodium  (Voltarol)
(Eye Drops)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
  • Diclofenac Sodium 0.1% Eye Drops (with preservative)
  • Diclofenac Sodium 0.1% Single Dose Eye Drops (preservative free)

    For use following consultant recommendation only
 
   
Ketorolac 0.5%  (Acular)
(Eye Drops)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
  • Ketorolac 0.5% Eye Drops (5ml) with preservative

    For use following consultant recommendation only
 
   
Cefuroxime (Aprokam)
(Intracameral Injection)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
  • Cefuroxime 50mg Injection (for intracameral use)
     
    For Eye theatre use only.
 
   
Sodium hyaluronate  (Provisc)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
  • Sodium hyaluronate (Provisc®) is used during surgical procedures on the eye.
 
   
Vision Blue
(Solution)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
  • Vision Blue 0.5ml Solution

    For Eye Theatre use only.
 
   
11.08.02  Expand sub section  Subfoveal choroidal neovascularisation
Aflibercept (Eylea)
(Solution for Injection)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
High Cost Medicine
  • Aflibercept Solution for Injection

Approved for use in line with NICE guidance:

  • NICE TA294 (wet age-related macular degeneration)
  • NICE TA305 (macula oedema secondary to central retinal vein occlusion)
  • NICE TA307 - NOT RECOMMENDED (metastatic colorectal cancer)
  • NICE TA346 (diabetic macular oedema)
  • NICE TA409 (macula oedema after branch retinal vein occlusion)

    Restricted to Consultant Ophthalmologist use only.
 
Link  Aflibercept - Information on the risk of osteonecrosis of the jaw (March 2016)
Link  NICE TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration (July 2013)
Link  NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion (February 2014)
Link  NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy (March 2014)
Link  NICE TA409: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion (September 2016)
Link  NICE TA486: Aflibercept for treating choroidal neovascularisation (November 2017)
Link  TA346: Aflibercept for treating diabetic macular oedema (July 2015)
   
Ranibizumab (Lucentis)
(Intravitreal Injection )
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
High Cost Medicine
  • Ranibizumab Solution for Intravitreal Injection 10mg/mL
    0.23mL

    For Consultant Opthalmologist use only.
    Use supported for the treatment of wet age-related macular degeneration in-line with NICE TA155
 
Link  NICE TA155: Ranibizumab and pegaptanib for the treatment of age-related macular degeneration (May 2012)
Link  NICE TA237: Ranibizumab for the treatment of diabetic macular oedema (Nov 2011)
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Green - Drugs suitable for generalised use in accordance with position summary. Inform primary care of need to prescribe using a TTO chart if in patient or Treatment Advice Note (TAN) if Outpatient.   

Amber

Amber - these drugs require specialist initiation or recommendation  

Amber SCG

Amber Share Care - Drugs suitable for generalist use, in accordance with position summary, normally following specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  

Red

Red - Drugs for specialist use only, in accordance with position summary. GPs should not be asked to prescribe these products.  

Red ULM

Red ULM - Unlicensed medicines for specialist use only, in accordance with position summary. GPs should not be asked to prescribe these products.  

Grey

Grey drugs - No formal commissioning position. Check appropriate CCG /NHSE commissioning list or contact CCG/NHSE Medicines Management team for advice. Fill in individual funding request for appropriate CCG/NHSE. This will need to be signed by the Chief Pharmacist and a copy of the relevant DTC submission attached.   

Black

Black - Drugs not routinely commissioned so should not usually be prescribed  

netFormulary